Luo Zichao, Shi Shuai, Jin Ling, Xu Lu, Yu Jing, Chen Hao, Li Xingyi
Institute of Biomaterials and Engineering, Wenzhou Medical University, Wenzhou 325035, PR China; Wenzhou Institute of Biomaterials and Engineering, Wenzhou 325035, PR China.
Institute of Biomedical Engineering, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical University, 270 Xueyuan Road, Wenzhou 325027, PR China.
Colloids Surf B Biointerfaces. 2015 Nov 1;135:556-564. doi: 10.1016/j.colsurfb.2015.07.079. Epub 2015 Jul 31.
Nanoparticles have been proven to be an effective vaccine delivery system that can boost immune responses to subunit vaccines. Herein, we developed and characterized a cationic polymeric polyethylene glycol2000-poly ϵ-caprolactone2000-polyethylenimine2000 (mPEG2000-PCL2000-g-PEI2000) micelle as a potent vaccine delivery system to boost the immune response in vivo. The micelles that we developed exhibited great antigen-loading capability and minimal cytotoxicity in vitro. Meanwhile, micelles facilitated OVA antigen uptake by dendritic cells both in vitro and in vivo. More importantly, a micelle-formulated OVA vaccine could significantly promote anti-OVA antibody production by 190-fold and potently enhance T cell proliferation and the secretion of IL-5 and IFN-γ. We attributed these effects to its ability to promote antigen uptake, antigen deposition, and germinal center formation. In conclusion, the mPEG2000-PCL2000-PEI2000 micelle that we developed has potential as potent vaccine delivery system to induce Th2 immune response.
纳米颗粒已被证明是一种有效的疫苗递送系统,可增强对亚单位疫苗的免疫反应。在此,我们开发并表征了一种阳离子聚合物聚乙二醇2000-聚ε-己内酯2000-聚乙烯亚胺2000(mPEG2000-PCL2000-g-PEI2000)胶束,作为一种有效的疫苗递送系统,以增强体内免疫反应。我们开发的胶束在体外表现出强大的抗原负载能力和最小的细胞毒性。同时,胶束在体外和体内均促进树突状细胞摄取OVA抗原。更重要的是,胶束配方的OVA疫苗可显著促进抗OVA抗体产生,提高190倍,并有力地增强T细胞增殖以及IL-5和IFN-γ的分泌。我们将这些作用归因于其促进抗原摄取、抗原沉积和生发中心形成的能力。总之,我们开发的mPEG2000-PCL2000-PEI2000胶束有潜力作为有效的疫苗递送系统来诱导Th2免疫反应。